EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multibinding inhibitors of cyclooxygenase-2



Multibinding inhibitors of cyclooxygenase-2



Official Gazette of the United States Patent & Trademark Office Patents 1258(4), May 28



Disclosed are multibinding compounds which inhibit cyclooxygenase-2 (COX-2), an enzyme which catalyzes the first committed step in the biosynthesis of prostaglandins. The multibinding compounds of this invention containing from 2 to 10 ligands covalently attached to one or more linkers. Each ligand is a moiety capable of binding to COX-2. The multibinding compounds of this invention are useful in the treatment inflammation, pain, fever and the like.

(PDF 0-2 workdays service: $29.90)

Accession: 035349696

Download citation: RISBibTeXText



Related references

Multibinding inhibitors of HMG-CoA reductase. Official Gazette of the United States Patent & Trademark Office Patents 1256(2), Mar 12, 2002

Multibinding inhibitors of microsomal triglyceride transferase protein. Official Gazette of the United States Patent & Trademark Office Patents 1250(2), Sep 11, 2001

Cyclooxygenase-2 inhibitors. 1,5-diarylpyrrol-3-acetic esters with enhanced inhibitory activity toward cyclooxygenase-2 and improved cyclooxygenase-2/cyclooxygenase-1 selectivity. Journal of Medicinal Chemistry 50(22): 5403-5411, 2007

Protective effect of cyclooxygenase-2 (COX-2) inhibitors but not non-selective cyclooxygenase (COX)-inhibitors on ethanol withdrawal-induced behavioural changes. Addiction Biology 10(4): 329-335, 2005

Cross-reactivity of cyclooxygenase 2 inhibitors in patients with a history of cutaneous reactions to cyclooxygenase 1 inhibitors. Annals of Allergy, Asthma & Immunology 94(1): 8-11, 2005

Evaluation of cyclooxygenase-1 and cyclooxygenase-2 expression and the effect of cyclooxygenase inhibitors in canine prostatic carcinoma. Veterinary and Comparative Oncology 2(1): 13-23, 2004

Differential effects of inhibitors of cyclooxygenase (cyclooxygenase 1 and cyclooxygenase 2) in acute inflammation. European Journal of Pharmacology 355(2-3): 211-217, 1998

Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitors. Journal of Immunology 163(1): 111-119, 1999

Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on ovarian carcinoma in vivo. International Journal of Molecular Sciences 12(1): 668-681, 2011

Cyclooxygenase inhibitors can modulate the expression of cdc 2 kinase-survivin independent of cyclooxygenase II activities. Journal of Investigative Medicine 50(2): 168A, March, 2002

Relative potency of nonsteroid anti-inflammatory drugs as inhibitors of cyclooxygenase-1 or cyclooxygenase-2. British Journal of Pharmacology 112(PROC SUPPL MAY): 183P, 1994

Cyclooxygenase-1 vs. cyclooxygenase-2 inhibitors in the induction of antinociception in rodent withdrawal reflexes. Neuropharmacology 40(7): 937-946, June, 2001

Cyclooxygenase inhibitors kill Burkitt lymphoma cells independent from cyclooxygenase 2. Naunyn-Schmiedeberg's Archives of Pharmacology 369(Suppl 1): R9, March, 2004

Radiosynthesis, biodistribution and PET imaging of potent and selective inhibitors of cyclooxygenase-1 and cyclooxygenase-2. Journal of Nuclear Medicine 36(5 SUPPL ): 49P, 1995

Techniques used to characterize the binding of cyclooxygenase inhibitors to the cyclooxygenase active site. Methods in Molecular Biology 644: 121-129, 2010